KOATE
Biological
Kedrion Biopharma Inc.
Total Payments
$318,953
Transactions
91
Doctors
24
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $13,750 | 2 | 0 |
| 2022 | $88,113 | 6 | 0 |
| 2020 | $41,564 | 9 | 3 |
| 2019 | $131,805 | 37 | 19 |
| 2018 | $43,722 | 37 | 7 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $124,408 | 35 | 39.0% |
| Unspecified | $110,086 | 11 | 34.5% |
| Consulting Fee | $66,050 | 14 | 20.7% |
| Travel and Lodging | $7,448 | 10 | 2.3% |
| Food and Beverage | $5,961 | 20 | 1.9% |
| Grant | $5,000 | 1 | 1.6% |
Payments by Type
General
$208,867
80 transactions
Research
$110,086
11 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Long Term Follow-up of Patients with Congenital Thrombotic Thrombocytopenia Purpura Receiving Plasma-Derviced Factor VIII Containing ADAMTS13 | Kedrion Biopharma, Inc. | $101,863 | 0 |
| A retrospective clinical data collection project of hemophilia A patients with inhibitors on immune tolerance induction with Koate-DVI | Kedrion Biopharma Inc. | $6,224 | 0 |
| Immune Tolerance Induction (ITI) Project: A Retrospective Clinical Data Collection Projectto Evaluate Physician Prescribing Behavior Relating to Immune Tolerance Induction (ITI) for Patients withHemophilia A | Kedrion Biopharma Inc. | $2,000 | 0 |
Top Doctors Receiving Payments for KOATE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Auora, CO | $125,597 | 16 |
| , MD | Hematology | New York, NY | $124,849 | 37 |
| , MD | Hematology | Columbus, OH | $6,630 | 4 |
| , MD | Blood Banking & Transfusion Medicine | Clayton, MO | $6,508 | 5 |
| , MD | Pediatric Hematology-Oncology | New Orleans, LA | $5,200 | 2 |
| , MD | Hematology | Hummelstown, PA | $4,115 | 4 |
| , MD | Pediatric Hematology-Oncology | Kansas City, MO | $3,190 | 2 |
| , M.D | Pediatric Hematology-Oncology | Westminster, CO | $3,170 | 3 |
| , MD | Hematology & Oncology | Dallas, TX | $2,694 | 1 |
| , M.D | Pediatric Hematology-Oncology | Ann Arbor, MI | $2,691 | 1 |
| Maissaa Janbain | Specialist | Metairie, LA | $2,679 | 1 |
| , M.D | Pediatrics | Edmond, OK | $2,662 | 1 |
| , M.D | Pediatric Hematology-Oncology | Delafield, WI | $2,660 | 1 |
| , MD | Hematology & Oncology | Dallas, TX | $2,634 | 1 |
| , MD | Pediatrics | Metairie, LA | $2,632 | 1 |
| , M.D | Hematology & Oncology | Atlanta, GA | $2,628 | 1 |
| , M.D | Pediatric Hematology-Oncology | Fresno, CA | $2,615 | 2 |
| Cindy Leissinger | Specialist | New Orleans, LA | $2,600 | 1 |
| , MD | Pediatric Hematology-Oncology | Horace, ND | $2,600 | 1 |
| , MD | Pediatrics | Washington, DC | $2,600 | 1 |
| , MD | Hematology & Oncology | Louisville, KY | $2,600 | 1 |
| , MD | Ophthalmology | Clarksville, MD | $2,025 | 1 |
| , M.D | Pediatric Hematology-Oncology | Los Angeles, CA | $1,800 | 1 |
| , M.D | Internal Medicine | Houston, TX | $1,500 | 1 |
| , M.D | Hematology | Aurora, CO | $73.27 | 1 |
Ad
Manufacturing Companies
- Kedrion Biopharma Inc. $217,090
- Kedrion Biopharma, Inc. $101,863
Product Information
- Type Biological
- Total Payments $318,953
- Total Doctors 24
- Transactions 91
About KOATE
KOATE is a biological associated with $318,953 in payments to 24 healthcare providers, recorded across 91 transactions in the CMS Open Payments database. The primary manufacturer is Kedrion Biopharma Inc..
Payment data is available from 2018 to 2023. In 2023, $13,750 was paid across 2 transactions to 0 doctors.
The most common payment nature for KOATE is "Honoraria" ($124,408, 39.0% of total).
KOATE is associated with 3 research studies, including "Long Term Follow-up of Patients with Congenital Thrombotic Thrombocytopenia Purpura Receiving Plasma-Derviced Factor VIII Containing ADAMTS13" ($101,863).